Los Angeles, CA
Migraine Treatment clinics in Los Angeles
Migraine care in Los Angeles blends headache medicine anchored around Cedars-Sinai, UCLA Health, Kaiser Permanente, and Keck Medicine of USC with integrative clinics offering IV magnesium, nerve blocks, and peptide protocols. Demand reflects an entertainment-industry and aesthetically motivated patient base.
Evidence-based care uses triptans, gepants, lasmiditan, and anti-CGRP monoclonals for acute and preventive treatment, plus onabotulinumtoxinA for chronic migraine and FDA-cleared neuromodulation devices. Regenerative and integrative adjuncts in Los Angeles, California include IV magnesium, occipital and sphenopalatine ganglion blocks, ketamine infusions for refractory cases, and HBOT (investigational for cluster headache). California Medical Board scrutiny of medspas, NP corporations, and stem cell claims shapes prescribing and compounding authority.
With migraine clinics on Regenerated.com in Los Angeles, patients can compare whether a clinic offers a proper headache workup, follows ICHD-3 criteria, and clearly distinguishes FDA-approved from off-label options.
LA Pain
- PRP Therapy
- Arthritis Treatment
- Migraine Treatment
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Aalto Hyperbaric Medical Group
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Oxygen Therapy
- Arthritis Treatment
- Migraine Treatment
Dr. Padra Nourparvar Stem Cell & PRP Institute of L.A.
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
R3 Stem Cell
- PRP Therapy
- Multiple Sclerosis (MS) Treatment
- Arthritis Treatment
- Lyme Disease Treatment
- Migraine Treatment
Delight Medical & Wellness Center
- Vitamin IV Therapy
- PRP Therapy
- Arthritis Treatment
- Migraine Treatment
- Peptide Therapy
TOPS Institute - Pain Management
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- IV Hydration
- Ketamine Therapy
Shamloo Elite Spine and Pain Institute
- PRP Therapy
- Migraine Treatment
- Hormone Replacement Therapy (HRT)
- TMJ Treatment
- Stem Cell Therapy
Regulatory context
A note on California's migraine treatment rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
California Medical Practice Act (Bus. & Prof. Code 2000 et seq.)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
California Psychology Licensing Law (Bus. & Prof. Code 2900 et seq.)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope. -
California Consumer Legal Remedies Act (Civ. Code 1750 et seq.)
Supports attorney general and private actions against deceptive medical device advertising.
The Medical Board of California investigates TMS clinics for off-label marketing, corporate practice of medicine violations, and improper supervision of technicians. California has a strong corporate practice of medicine doctrine, meaning non-physician-owned entities cannot employ physicians or control clinical decisions at TMS or neurofeedback clinics. The attorney general and district attorneys have pursued actions against neurofeedback providers advertising unproven cures for autism, ADHD, and traumatic brain injury. California insurers require documented failed antidepressant trials before covering TMS for major depression.